Recognition and Treatment of Dysglycemia. AGS - Acute Glucose Service
AGS
1 other identifier
interventional
600
1 country
1
Brief Summary
AGS (Acute Glucose Service ) is an inpatient glucose management service consisting of Nurse Practitioner and physician. Team manages not - consulted- based preoperative assessment, perioperative glucose control, patient education and supervision, but also transition of care postoperatively. The goal is to detect and treat dysglycemias , but also provide an active and constantly ongoing education to other hospital teams. AGS improves better overall- survival of arthroplastic patients and is an effective way to recognize and treat dysglycemias and to organize constantly ongoing education.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2017
CompletedStudy Start
First participant enrolled
September 26, 2017
CompletedFirst Posted
Study publicly available on registry
October 11, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedOctober 11, 2017
October 1, 2017
2.3 years
September 19, 2017
October 10, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Survival
Improved survival
1-5 years
Secondary Outcomes (1)
Complications
1-5 years
Study Arms (2)
AG service
ACTIVE COMPARATORIn the "Active Comparator Arm": Screening, follow-up and treatment of dysglycemias in the elective orthopedic prosthetic surgery (knee / hip) patients in the Päijät-Häme Central hospital will be optimized and individualized in the patients in personal manner.
Without AG service
NO INTERVENTIONIn the "No intervention Arm": Screening, follow-up and treatment of dysglycemias in the elective orthopedic prosthetic surgery (knee / hip) patients follows the current protocol of Päijät-Häme Central hospital.
Interventions
The AG service group is divided to two 200 patients groups: 1) with AGS 2) with AGS extended to first control in 3 months (AG- nurse may be contacted by phone). Patients are followed up up to 5 years.
Eligibility Criteria
You may qualify if:
- Patients aged \> 18 years
- Elective knee and hip arthroplasty patients
You may not qualify if:
- Patients who are incompetent to give informed consent
- Patients who are incompetent to assess their Quality-of-Life personally
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Päijät-Häme Central Hospital
Lahti, 15850, Finland
Related Publications (1)
Ylikoski M, Jokinen JJ, Lahtela J, Kauppi MJ, Huhtala H, Immonen H, Tiihonen R. Perioperative hyperglycaemia in elective arthroplasties. Should we do better? Acta Anaesthesiol Scand. 2020 Oct;64(9):1253-1261. doi: 10.1111/aas.13666. Epub 2020 Jul 30.
PMID: 32615649DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Marianne Ylikoski, MD
Päijät Häme Central Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- CRA
Study Record Dates
First Submitted
September 19, 2017
First Posted
October 11, 2017
Study Start
September 26, 2017
Primary Completion
December 31, 2019
Study Completion
December 31, 2025
Last Updated
October 11, 2017
Record last verified: 2017-10
Data Sharing
- IPD Sharing
- Will not share